Evidence map›Paper›PMID 27538959›Full record

ArticleNeurochemical research2016

Anti-neuroinflammatory Effect of Emodin in LPS-Stimulated Microglia: Involvement of AMPK/Nrf2 Activation.

Sun Young Park, Mei Ling Jin, Min Jung Ko, Geuntae Park, Young-Whan Choi

Abstract read
PubMed Publisher
In one paragraph

Article in Neurochemical research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
17.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 85 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Preclinical Evidence and Underlying Mechanisms ofJournal of pharmacopuncture · 2024
    Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Sun Young ParkBio-IT Fusion Technology Research Institute, Pusan National University, Busan, 609-735, South Korea.
Mei Ling JinBio-IT Fusion Technology Research Institute, Pusan National University, Busan, 609-735, South Korea.
Min Jung KoDepartment of Nanomaterials Engineering, Pusan National University, Busan, 609-735, South Korea.
Geuntae ParkDepartment of Nanomaterials Engineering, Pusan National University, Busan, 609-735, South Korea. gtpark@pusan.ac.kr.
Young-Whan ChoiDepartment of Horticultural Bioscience, Pusan National University, Miryang, 627-706, South Korea. ywchoi@pusan.ac.kr.
Pusan National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

AMPK/Nrf2 signaling regulates multiple antioxidative factors and exerts neuroprotective effects. Emodin is one of the main bioactive components extracted from Polygonum multiflorum, a plant possessing important activities for human health and for treating a variety of diseases. This study examined whether emodin can activate AMPK/Nrf2 signaling and induce the expression of genes targeted by this pathway. In addition, the anti-neuroinflammatory properties of emodin in lipopolysaccharide (LPS)-stimulated microglia were examined. In microglia, the emodin treatment increased the levels of LKB1, CaMKII, and AMPK phosphorylation. Emodin increased the translocation and transactivity of Nrf2 and enhanced the levels of HO-1 and NQO1. In addition, the emodin-mediated expression of HO-1 and NQO1 was attenuated completely by an AMPK inhibitor (compound C). Moreover, emodin decreased dramatically the LPS-induced production of NO and PGE

Indexed as

AMP-Activated Protein KinasesAnimalsAntioxidantsEmodinLipopolysaccharidesMiceMicrogliaNF-E2-Related Factor 2Nitric OxideNitric Oxide Synthase Type IIPhosphorylationSignal TransductionTumor Necrosis Factor-alphaAMP-Activated Protein KinasesAntioxidantsEmodinLipopolysaccharidesNfe2l2 protein, mouseNF-E2-Related Factor 2Nitric OxideNitric Oxide Synthase Type IINos2 protein, mouseTumor Necrosis Factor-alphaAMPKAnti-neuroinflammationEmodinMicrogliaNrf2

Identifiers

PMID27538959
OpenAlexW2510914029

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.